111 (NASDAQ:YI – Get Free Report) and Privia Health Group (NASDAQ:PRVA – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation and institutional ownership.
Volatility and Risk
111 has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500.
Institutional & Insider Ownership
21.3% of 111 shares are owned by institutional investors. Comparatively, 94.5% of Privia Health Group shares are owned by institutional investors. 43.9% of 111 shares are owned by insiders. Comparatively, 5.7% of Privia Health Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Analyst Recommendations
This is a summary of recent ratings and price targets for 111 and Privia Health Group, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| 111 | 1 | 0 | 0 | 0 | 1.00 |
| Privia Health Group | 0 | 3 | 7 | 0 | 2.70 |
Privia Health Group has a consensus price target of $31.20, indicating a potential upside of 27.09%. Given Privia Health Group’s stronger consensus rating and higher possible upside, analysts clearly believe Privia Health Group is more favorable than 111.
Profitability
This table compares 111 and Privia Health Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| 111 | -1.01% | N/A | -4.86% |
| Privia Health Group | 1.43% | 4.20% | 2.38% |
Valuation and Earnings
This table compares 111 and Privia Health Group”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| 111 | $10.48 billion | 0.00 | -$9.65 million | ($1.60) | -1.77 |
| Privia Health Group | $2.12 billion | 1.48 | $22.92 million | $0.26 | 94.42 |
Privia Health Group has lower revenue, but higher earnings than 111. 111 is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.
Summary
Privia Health Group beats 111 on 11 of the 14 factors compared between the two stocks.
About 111
111, Inc. is a China-based digital healthcare company that connects pharmaceutical manufacturers, distributors, pharmacies, healthcare providers and consumers through online platforms and technology-enabled services. The company operates a pharmaceutical business-to-business platform that supplies medicines and healthcare products to pharmacies and other customers. It also offers online pharmacy services and digital tools intended to support purchasing, inventory management and other pharmacy operations.
About Privia Health Group
Privia Health Group, Inc. is a physician enablement company that partners with independent medical groups, health systems and other providers. Its technology-enabled platform is designed to help physicians manage their practices and deliver coordinated care, while retaining their clinical independence. The company provides practice management, technology, care coordination and population health services. It also helps providers participate in value-based care arrangements, which tie payments more closely to the quality and efficiency of care.
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
